Nektar Therapeutics
F:ITH0
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Nektar Therapeutics
F:ITH0
|
US |
|
H
|
Hanhua Financial Holding Co Ltd
F:5HF
|
CN |
Wall St Price Targets
ITH0 Price Targets Summary
Nektar Therapeutics
According to Wall Street analysts, the average 1-year price target for ITH0 is 113.07 EUR with a low forecast of 58.46 EUR and a high forecast of 145.85 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is ITH0's stock price target?
Price Target
113.07
EUR
According to Wall Street analysts, the average 1-year price target for ITH0 is 113.07 EUR with a low forecast of 58.46 EUR and a high forecast of 145.85 EUR.
What is the Revenue forecast for Nektar Therapeutics?
Projected CAGR
48%
Over the last 13 years, the compound annual growth rate for Revenue has been -3%. The projected CAGR for the next 8 years is 48%.
What is the Gross Profit forecast for Nektar Therapeutics?
Projected CAGR
47%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 1%. The projected CAGR for the next 8 years is 47%.
